Outcome at Six Months After Primary Percutaneous Coronary Interventions Performed at a Rural Satellite Center of Sindh Province of Pakistan.

acute myocardial infarction angiography culprit vessel des pci percutaneous coronary intervention

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
28 May 2020
Historique:
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 4 7 2020
Statut: epublish

Résumé

Introduction Primary percutaneous coronary intervention (PPCI) is now a well-established treatment of acute ST-elevation myocardial infarction (STEMI). For the first time in Pakistan, various off-site satellite centers are established to perform PPCI 24-hours. Our population mainly resides in the rural area with low literacy rate and poor socioeconomic conditions. The majority of the patients who are presented in the satellite center had either never received any long-term treatment plan or were non-compliant to their medication. The objective of this study was to determine the outcome of patients at six months who underwent primary PCI at a rural satellite center of Sindh, Pakistan. Methods This study was conducted at Larkana satellite center of National Institute of Cardiovascular Diseases, Karachi. Patients who underwent PPCI for STEMI from October 2017 to March 2018 were enrolled in the study. In case of death of the patient, data were obtained from the attendant of the deceased. Patients, on follow-up visits, were interrogated for post-procedure symptoms. Results A total of 271 patients were enrolled in the study. The mean age ± standard deviation of patients was 54.84 ± 10.64 years. The most common culprit artery was left anterior descending (LAD) artery with 161 (59.4%) patients, followed by right coronary artery (RCA) with 98 (36.2%) patients. Only 41 (15%) patients had a three-vessel disease, while 141 (52%) patients had single-vessel disease. On follow-up, 70 (25.8%) patients complained of chest pain grade II, 20 (7.4%) complained of shortness of breath (SOB) grade II, 44 (16.2%) complained of vertigo, and 16 (5.9%) complained of nonspecific weakness. The mortality rate of 6.3% (17) was observed after six months of PPCI. The mortality rate was found to be lower for patients with LAD disease (p = 0.036) and higher among patients with RCA as the culprit artery (p = 0.045). The mortality rate was significantly associated with the number of diseased vessels and the type of stent deployed. Conclusion Primary PCI, at a rural satellite center, has an overall positive outcome. Steps should be taken to provide free medication along with encouragement towards compliance of dual antiplatelet medication. Furthermore, the facility for subsequent procedures should be provided at the same set-up.

Identifiants

pubmed: 32617219
doi: 10.7759/cureus.8345
pmc: PMC7325348
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e8345

Informations de copyright

Copyright © 2020, Mujtaba et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet. 2015 Aug 15;386(9994):665-71
pubmed: 26347918
Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004979
pubmed: 30606051
J Am Coll Cardiol. 2015 Mar 17;65(10):963-72
pubmed: 25766941
Eur Heart J. 2015 Dec 14;36(47):3320-31
pubmed: 26417060
Circulation. 2006 Jun 20;113(24):2803-9
pubmed: 16769908
Cardiol Res. 2012 Apr;3(2):67-72
pubmed: 28348674
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Circ Cardiovasc Interv. 2016 Dec;9(12):
pubmed: 27932532
Int J Cardiol. 2013 Nov 15;169(4):254-61
pubmed: 24071385
N Engl J Med. 2013 Sep 19;369(12):1115-23
pubmed: 23991625
Open Heart. 2018 Sep 5;5(2):e000852
pubmed: 30228908
Neth Heart J. 2016 Oct;24(10):581-8
pubmed: 27595816
Am J Cardiol. 2006 Mar 15;97(6):817-22
pubmed: 16516582
J Cardiovasc Pharmacol Ther. 2011 Mar;16(1):24-42
pubmed: 20924098
Interv Cardiol Clin. 2016 Apr;5(2):221-237
pubmed: 28582206
Lancet. 2003 Jan 4;361(9351):13-20
pubmed: 12517460
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122
pubmed: 22070834
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115
pubmed: 27036918
JAMA. 2014 Nov 19;312(19):2019-27
pubmed: 25399277
EuroIntervention. 2008 May;4(1):64-70
pubmed: 19112781
N Engl J Med. 2012 May 10;366(19):1814-23
pubmed: 22571203
J Am Coll Cardiol. 2004 Jun 2;43(11):1943-50
pubmed: 15172395
Eur Heart J. 2006 Apr;27(7):779-88
pubmed: 16513663
Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):9-13
pubmed: 23337379
Circulation. 2006 Nov 7;114(19):2019-25
pubmed: 17075010

Auteurs

Syed F Mujtaba (SF)

Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Muhammad N Khan (MN)

Interventional Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Hina Sohail (H)

Adult Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Jawaid A Sial (JA)

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Musa Karim (M)

Statistics, National Institute of Cardiovascular Diseases, Karachi, PAK.

Tahir Saghir (T)

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Kiran Abbas (K)

Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Medicine and Surgery, Sindh Medical College, Karachi, PAK.

Moiz Ahmed (M)

Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Medicine and Surgery, Sindh Medical College, Karachi, PAK.

Nadeem Qamar (N)

Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Classifications MeSH